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Neuronidization to determine the cell type speciﬁc accumulation of the intron of the
latency-associated transcript (LAT) in tissues in HSV-2 LAT transgenic mice in which LAT expression is driven
by its native promoter. We identiﬁed LAT in multiple cell types in most tissues analyzed from HSV-2 LAT
transgenic mice. While weak to moderate signals were seen in brain and spinal cord neurons, epithelial cells,
and muscle cells, the strongest signals were detected in neurons from dorsal root and trigeminal ganglia.
About 70–86% of neurons in these ganglia were LAT-positive with varying signal intensities, while cells
surrounding the neurons were LAT-negative. The frequency of A5 or KH10-positive neurons was similar in
LAT-positive and total neurons. These data indicate that HSV-2 LAT promoter activity is not restricted to
neurons and that LAT accumulation in ganglionic neurons is likely regulated by cell-speciﬁc factors.
Published by Elsevier Inc.IntroductionHuman herpesvirus 2 or herpes simplex virus type 2 (HSV-2) is
usually transmitted by sexual contact and causes genital lesions. After
primary infection of the genital region, HSV-2 establishes life long
latent infection in the dorsal root ganglia (DRG) that innervate the site
of primary infection. The virus resides in sensory neurons and
periodically reactivates to cause lytic infection in the peripheral
tissues. During latent infection, the viral DNA persists in sensory
neurons while its gene expression is extremely restricted. Only a
single family of abundant viral RNAs, the HSV-2 latency-associated
transcripts (LATs), accumulates to a level detectable by in situ
hybridization (ISH) (Croen et al., 1991; Tenser et al., 1991).
The LAT locus is about 9 kb in length and is located in the long
repeat segments ﬂanking the unique long (UL) fragment of the HSV-2
genome. The LAT gene extends anti-sense to the ICP0 and ICP34.5
genes (McGeoch et al., 1991). HSV-2 LATs have not been consistently
shown to encode protein products during virus infection. However, at
least 2 species of LATs are detectable in latently infected ganglia. The
primary transcript is about 8.3 kb long and can be detected by
Northern blot (Krause et al., 1991). The most abundant HSV-2 LAT (thenc.major LAT) is believed to be a 2.2 kb stable intron (LAT intron), like the
major LAT of HSV-1, spliced from the primary transcript (McGeoch
et al., 1991). The HSV-2 LAT is the only viral RNA that can be readily
detected via ISH in latently infected neurons (Burke et al., 1991; Croen
et al., 1991; Tenser et al., 1991) and has been recognized as the
hallmark of HSV-2 latency. Deletion of a Not I fragment (nt −392 to
+240 relative to the HSV-2 LAT transcription start site) diminishes the
ability of the virus to reactivate from latency (Krause et al., 1995). The
HSV-2 LAT encodes two microRNAs (miR-I, miR-II) that inhibit
expression of the viral ICP34.5 gene, and a third microRNA (miR-III)
that silences the expression of ICP0; these microRNAs may have
important roles in viral latency (Tang et al., 2008, 2009). The HSV-1
LAT gene has been studied more extensively. It has been reported that
deletion of a 1.8 kb fragment beginning at the HSV-1 LAT promoter
increased productive-cycle gene expression during acute and latent
infection in mice (Chen et al., 1997; Garber et al., 1997) which may be
due to the ability of the LAT gene to promote assembly of
heterochromatin on viral lytic-gene promoters (Wang et al., 2005b),
and/or to encode miRNAs that regulate viral genes (Umbach et al.,
2008). HSV-1 LAT may also facilitate viral latency by blocking
apoptosis of infected neurons (Perng et al., 2000; Thompson and
Sawtell, 2001).
We have previously studied HSV-2 LAT gene expression both in
vitro and in vivo. Transfection of cells with a reporter gene linked to a
DNA fragment located between nucleotide −102 to +34, relative to the
transcription initiation site of the LAT, results in constitutive
Fig. 1. Schematic representation of the HSV-2 genome, LAT gene region, and the LAT transgene cassette. The top line represents the HSV-2 genome, with terminal (TR) and internal
(IR) long (L) and short (s) repeats ﬂanking the unique long and short segments (UL and Us, respectively). The second line shows the LAT gene region. The oval represents the LAT
promoter and the open box represents the segment coding for the LAT intron. The minor and major LATs and the overlapping gene ICP0 are depicted below. The last line represents
the LAT transgene cassette. The arrows below the transgene represent the RNA probes used for ISH. Probe L was used for ISH in Figs. 2, 3, 5, 6, 7 and probe S for ISH in Fig. 4.
Fig. 2. LAT accumulation in sensory ganglion neurons is heterogeneous. The LAT intronwas detected in sensory ganglia by ISH. Panels A, D, and G show tissues fromwild-type (WT)
mouse trigeminal ganglia (TG), thoracic dorsal root ganglia (tDRG), and sacral dorsal root ganglia (sDRG), respectively, stained in parallel with sections from transgenic mice. ISH
signal (blue staining) was seen in the nuclei of 70–86% of neurons in sections fromHSV-2 LAT transgenic (TGN) mouse TG (B, C), tDRG (E, F), and sDRG (H, I). Images in each roware at
the same magniﬁcation and the scale bar=50 μm. Arrows point to neurons in which nuclei are clearly visible but with little or no detectable LAT accumulation.
80 K. Wang et al. / Virology 386 (2009) 79–87
Fig. 3. LAT is detectable in neurons of other nervous tissue. Sections from brain and
spine were examined by ISH for HSV-2 LAT. Hippocampus from a wild-type mouse (A)
or transgenic mouse (B), and spinal cord from a wild-type mouse (C) or transgenic
mouse (D). Positive signals (blue staining) are seen in nuclei of neurons in sections from
transgenic mouse. Scale bar=50 μm.
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cell lines (Wang et al., 1995). Additionally, a region further upstream of
the HSV-2 LAT promoter, nucleotides −392 to −102 relative to the
transcription initiation site, strongly increases promoter activity in
neuronal cell lines (Wang et al., 1995) and in latently infected sensory
ganglia of guinea pigs (Wang et al., 1997).
By studying single neurons in human trigeminal ganglia that were
latently infected with HSV-1, a virus very closely related to HSV-2, we
found that HSV-1 LAT is not uniformly expressed in all latently
infected neurons. Some neurons harbor many copies of HSV-1
genomic DNA, but accumulate no detectable LAT by ISH (Wang et
al., 2005a). This ﬁnding suggests that regulation of LAT expression in
neurons is complex and varies among different neurons in the same
ganglion.Fig. 4. LAT accumulation in neurons does not correlate with neuronal markers A5 or KH10.
Rhodamine-labeled anti-DIG-AP Fab fragments (A, D), then stained for neuronal markers A5
Scale bar=20 μm.Previously we constructed mice transgenic for a 5.5 kb DNA
fragment which contains the 5′ portion of the HSV-2 LAT gene
beginning 1167 bp upstream of the transcription initiation site, and
ending 1170 bp downstream of the splicing adapter site of the LAT
intron (corresponding to nucleotide 118,332 to 123,608 of HSV-2
strain HG52) (Fig. 1). The accumulation of the LAT intron was
detected in the nucleus of neurons in the trigeminal ganglia (TG) by
ISH, and it was also detected in brain by Northern blot assay (Wang
et al., 2001).
While our transient expression results indicated that the HSV-2
LAT promoter is active in some non-neuronal cells in culture, it was
unknownwhether this promoter was active in different types of non-
neuronal cells, including satellite cells, in vivo. To further characterize
HSV-2 LAT promoter activity in various types of cells, we examined
multiple tissues from HSV-2 LAT transgenic mice by ISH. Here we
show that in HSV-2 LAT transgenic mice, the LAT intron is detectable
by ISH not only in neurons, but also in several other tissues and cell
types, and that HSV-2 LAT expression varies widely among different
neurons. These ﬁndings suggest that LAT promoter activity and/or the
stability of the LAT intron is regulated by different cell factors
expressed in various cells including different sensory neurons.
Results
Accumulation of LAT intron in neurons is heterogenous
Trigeminal ganglia (TG), thoracic dorsal root ganglia (tDRG), sacral
dorsal root ganglia (sDRG), brain, and spinal cord from LAT transgenic
and wild-type mice were assayed by in situ hybridization (ISH) using a
biotin labeled RNA probe antisense to the HSV-2 LAT intron (Fig. 1).
LAT was detected in all of the nervous system tissues mentioned
above; however, the intensity of the staining varied from tissue to
tissue, and from cell to cell. About 70–86% of neurons in the sensory
ganglia were positive for LAT, with blue staining distributed through-
out the nuclei. The intensity of the signal ranged from strong (dark
blue) tomoderate (blue) toweak (light blue), and the strongest signals
were seen in sDRG neurons (Fig. 2). Neurons with weak staining were
scattered throughout the brain. More LAT positive neurons, about 60%,
were seen with moderate to weak staining in in hippocampus
(Fig. 3B). Moderate signals were also detected in some of the neurons
in the spinal cord (Fig. 3D). The ISH signal was present only in nuclei
and interestingly was solely detected in neurons. Despite the fact that
non-neuronal cells in the nervous system should have the same copyDRG sections were ﬁrst hybridized with a DIG-labeled LAT probe and visualized with
(B) or KH10 (E). Merged images are shown in C (LAT and A5) and in F (LAT and KH10).
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neuronal cells had undetectable ISH signals. The differences in signal
intensity noted among different cell types are due to differences in LAT
expression and/or accumulation, and not to differences in copy
number of the LAT transgene in different cell types in the transgenic
line. While differences in transgene copy number in different cells
have been reported in mosaic mice, this did not occur in the LAT
transgenic lines since the copy numbers of the transgene in both line
5221 and line 5238 were maintained from founder mice to their
offspring at levels consistent with Mendelian genetics.
To determine if accumulation of LAT in ganglia correlates with
neuronal markers A5 or KH10, DRG sections were initially hybridized
with a DIG-labeled LAT probe and visualized with Rhodamine-labeled
anti-DIG-AP Fab fragments, followed by staining with a monoclonal
antibody speciﬁc for neuronal markers A5 or KH10 and FITC-labeled
secondary antibody (Fig. 4). Careful analysis of stained tissue sections
revealed that 9.9% (105/1059) of neurons stained with monoclonalFig. 5. LAT is detectable in epithelial cells by ISH. Mouse organs were examined by ISH for LA
intestine (D), large intestine (F), bladder (H), urethra of the penis (J), vagina (L), and uterus (N
(P), hepatocytes (R), renal tubules (T), and lungs (V) of transgenic mice, but was absent from c
column are at the same magniﬁcation and the scale bar=50 μm.antibody A5 and 19.7% (161/816) of neurons stained with monoclonal
antibody KH10. Amongst these sections we chose those areas with the
best dual staining for both LATand cell surfacemarkers and found that
9.8% (21/215) of LAT-positive neurons also stained with monoclonal
antibody A5 and 15% (35/233) of LAT-positive neurons stained with
monoclonal antibody KH10.
The LAT intron is detectable in epithelial cells by ISH
In addition to the nervous system, LAT-positive cells were also
detected by ISH in epithelial cells in many organs. Moderate ISH
signals were seen in some epithelial cells lining the stomach of
transgenic mice (Fig. 5B). Weak signals were found in some epithelial
cells lining the small and large intestine (Figs. 5D, F). ISH signal was
also detected in some epithelial cells lining the bladder, urethra of the
penis, and vagina (Figs. 5H, J, L,). Very weak signal was noted in some
epithelial cell in the uterus (Fig. 5N). The signal intensity increasedT. LAT was detected (blue staining) in nuclei of epithelial cells of the stomach (B), small
) of transgenic (TGN)mice. LAT was also detectable in nuclei of epithelial cells of the skin
orresponding tissues of wild-type (WT)mice (A, C, E, G, I, K, M, O, Q, S,U). Images in each
Fig. 5 (continued).
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indicating that in these tissuesmature cells accumulatemore LAT than
immature cells. Keratinized epithelial cells in the skin expressed
considerably less LAT than other epithelial cells (Fig. 5P). LAT was also
detected in the cells lining the ducts of the hair follicles (Fig. 5P). LAT
was detected in about 30% of hepatocytes with signal intensities
ranging from moderate to weak (Fig. 5R). Weak ISH signal was found
in some cells in renal tubules (Fig. 5T). Moderate signals were seen in
some epithelial cells lining the bronchioles of the lungs (Fig. 5V). In all
of the epithelial cells, ISH signals were only detected in the nuclei of
the cells.
The LAT intron is detected in other types of cells by ISH
Moderate to weak signals for LAT were seen in cardiac and skeletal
muscle cells (Figs. 6B, D). Moderate signals were also detected in
basement membrane cells of the testes and follicular granulosa cells of
the ovaries (Figs. 6F, H) and in the wall of lung alveoli (Fig. 6J). No ISH
signal was detected in splenocytes and thymocytes (Figs. 7B, D).Discussion
To better understand how the LAT intron is expressed and
accumulates in diverse tissues, we examined multiple tissues from
HSV-2 LAT transgenic mice by ISH. In contrast to a prior report for
HSV-1 LAT transgenic mice in which LAT was only detected in sensory
ganglia by ISH (Gussow et al., 2006), HSV-2 LATwas detected by ISH at
various signal intensities in nearly all tissues from HSV-2 LAT
transgenic mice. We detected LAT in epithelial cells from multiple
organs indicating that the LAT promoter can be recognized by
transcription factor(s) common in epithelial cells. In addition, LAT
expression in other cell types including muscle cells, follicular
granulosa cells of the ovary, and basement membrane cells of the
testes suggests that either the promoter of the HSV-2 LAT gene has
basal activity in multiple cell types or that different cis-elements in
the promoter can interact with different transcription factors in
various cell types.
Despite the observation that the LAT intron was detected in
multiple cell types outside the nervous system, LAT was not detected
Fig. 6. LAT is detected in other types of cells. Sections from heart, skeletal muscle from the hind limb, testes, ovary, and lung were examined by ISH for HSV-2 LAT. Positive signals
(blue staining) were visible in the nuclei of myocardial cells (B) and skeletal muscle (D) from transgenic (TGN) mice. LAT was also detected in basement membrane cells of the testes
(F), in follicular granulosa cells of the ovaries (H), and in thewall of lung alveoli (J) of transgenic mice, but was absent in the corresponding tissues (A, C, E, G, I) of wild-type (WT)mice.
Images in each column are at the same magniﬁcation and the scale bar=50 μm.
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line 5221 and line 5238. The absence of LAT in non-neuronal cells in
ganglia during latency is due to the lack of HSV genomes in these cells
(Gressens andMartin, 1994; Mehta et al., 1995; Sawtell, 1997;Wang et
al., 2005a). However, when the LAT transgene is present at 40 copies
per cell in the transgenic mice, and LAT accumulates at high levels in
the neurons, LAT is still not detected by in situ hybridization in the
non-neuronal cells that also have the LAT transgene. Therefore, if the
LAT promoter has strong basal activity (since LAT is detected in
multiple cell types outside the nervous system), then non-neuronal
cells in sensory ganglia may have factors that either inhibit expression
from the LAT promoter or that degrade the LAT transcript. The lack of
LAT expression and/or accumulation in satellite cells, which surround
neurons, is particularly interesting.While satellite cells can be infected
during acute HSV infection (Georgsson et al., 1987), latent HSV DNA
has not been detected in these cells (Gressens and Martin, 1994;
Mehta et al., 1995; Sawtell, 1997; Wang et al., 2005a). Based on
ﬁndings in our study we speculate that lack of LAT expression and/oraccumulation in satellite cells might be partly responsible for the
failure of HSV to establish latency in these cells.
Our results with HSV-2 transgenic mice, inwhich LATwas detected
by ISH in multiple tissue types, are different from what was reported
for transgenic mice which contained the HSV-1 LAT promoter, ﬁrst
exon, and LAT intronwhere LAT was only detectable by ISH in neurons
in trigeminal and dorsal root ganglia, and in small numbers of neurons
in the thalamus and spinal cord (Gussow et al., 2006). While LAT RNA
was detected in other tissues examined, including the heart, lung,
kidney, thymus, liver, spleen, and skin in the HSV-1 transgenic mice
using real time PCR; the spliced LAT intron was not detected by
Northern blotting or ISH in non-neuronal tissues. Several reasons
might explain the difference in the ISH results in these two studies.
First, ISH is a complex procedure and the sensitivity of the assay might
differ from one laboratory to another. Second, while HSV-1 and HSV-2
share a high level of nucleotide homology between their genomes,
small differences in the promoter sequences such as the GC-rich cis-
element in HSV-2 LAT promoter (Wang et al., 1995) which is not
Fig. 7. LAT is not detected in splenocytes or in thymocytes. Sections from spleen and
thymus were examined by ISH for HSV-2 LAT. No positive signals (blue staining) are
visible in splenocytes (B) or thymocytes (D) of transgenic (TGN) and wild-type (WT)
mice. Scale bar=50 μm.
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activities. In addition, the slightly longer upstream region in the HSV-2
LAT construct might also contribute to the different promoter
activities. Lekstrom-Himes et al. (1998) showed that in transient
transfection assays, the HSV-2 LAT promoter was 6- to 10-fold more
active than the HSV-1 LAT promoter in driving reporter gene
expression. Bertke et al. (2007) constructed chimeric HSV in which
the HSV-2 LAT promoter or 2.5 kb of the HSV-2 LAT sequence was
replaced with the corresponding region from HSV-1, and found that
the LAT sequence, not the LAT promoter region, was required for type-
speciﬁc reactivation of HSV-2 and virus neurotropism. Therefore,
differences in the LAT promoter or LAT sequence between HSV-1 and
HSV-2 might result in difference in expression or accumulation of LAT
in various tissues.
Other reasons might also explain the differences between our
results with HSV-2 LAT transgenic mice and those of Gussow et al.
(2006) with HSV-1 LAT transgenic mice. The insertion site(s) in the
cellular genome and the copy number of transgenes per cell in the
HSV-1 and HSV-2 transgenic mice might inﬂuence expression in
various tissues. The transgenic mice we used (heterozygous mice of
lines 5221 and 5238) have about 10 and 40 copies of the LAT transgene
per cell (Wang et al., 2001), while the HSV-1 transgenic mice have
about 1 copy of the transgene per cell (Gussow et al., 2006). Hoshino
et al. (2008) showed that mice latently infected with HSV-2 have a
median of 14 viral genomes per cell; since there are two copies of LAT
per viral genome, therewould be amedian of 28 copies of LAT DNA per
latently infected cell, which is similar to the number of LAT transgenes
per cell in our mice. Similarly, mice latently infected with HSV-1
contain a median of 14–15 copies of HSV-1 genome per neuron
(Sawtell et al., 1998); therefore, the low number of copies of HSV-1 LAT
per neuron in the HSV-1 transgenic micemay have resulted in low LAT
expression and failure to detect LAT in other tissues by ISH.
We found that LAT was expressed at different levels in individual
neurons in sensory ganglia of the HSV-2 LAT transgenic mice. This is
consistent with observations in HSV-1 latently infected mice and in
human sensory ganglia that more neurons are positive for HSV DNA
than for LAT (Gressens and Martin, 1994; Mehta et al., 1995; Sawtell,
1997; Wang et al., 2005a), and that expression of LAT does notcorrelate with the latent viral DNA load in the same neurons (Wang et
al., 2005a). Our observation here further conﬁrms that LAT accumula-
tion in neurons is tightly regulated by factors in addition to the copy
number of its genomic DNA. The population of neurons foundwithin a
single sensory ganglion is diverse in morphology, function, and gene
expression. LAT may be expressed at different levels in certain type of
neurons due to cellular features such as transcription factors,
chromatin modiﬁcations, and possibly cellular miRNAs that target
LAT. While a previous report noted that neuronal markers A5 and
KH10 directly correlated with the accumulation of HSV-1 and HSV-2
LAT, respectively, in latently infected mouse ganglia (Margolis et al.,
2007; Yang et al., 2000), we did not observe a similar correlation for
KH10 in HSV-2 LAT transgenic mice. This ﬁnding supports the
previous hypothesis that the correlation of LAT expression with A5
or KH10 expression in latently infected ganglia is due to which cell
types are infected by HSV-2, rather thanwhich cells are able to express
HSV-2 LAT (Margolis et al., 2007).
Materials and methods
HSV-2 LAT transgene and transgenic mice
HSV-2 LAT transgenic micewere previously described (Wang et al.,
2001). The 5511 bp LATpa transgene consists of a DraIII-PstI fragment
from HSV-2 strain 333 genomic DNA (nucleotides 118,337 to 123,610
of HSV-2 genome based on the sequence of HSV-2 HG52) and begins
1167 bp upstream of the LAT transcription initiation site, encompasses
the LAT promoter and some of its upstream region, the ﬁrst exon, the
entire 2.2 kb LAT intron, and 1170 bp downstream of the LAT intron
splicing adapter site. The LAT transgene encompasses miR-III, a
microRNA encoded by the HSV-2 LAT gene (Tang et al., 2009). The
polyadenylation signal of bovine growth hormone gene was added to
the 3′ end of the viral fragment to complete the transcription unit,
LATpa (Fig. 1). The LATpa cassette was introduced into C57BL/6 mice
by microinjecting mouse pronuclei with the transgene DNA fragment.
Two mouse colonies, lines 5221 and 5238, were established from two
transgenic founders. Crossing homozygous mice of line 5221 or line
5238 with wild-type C57BL/6 mice yielded heterozygous mice which
have 10 or 40 copies of the LAT transgene per cell, respectively. These
heterozygous mice were used since it is less likely that a phenotype
would be due to insertional inactivation of a mouse gene by the LAT
transgene, because heterozygotes will have at least one copy of each
wild-type mouse gene.
The amount of LATaccumulation in TG and liver, other organs were
not tested, was not gender or age dependent when RNA from 6-week
to 2-year old mice were assayed by real-time PCR (unpublished data).
Preparation of tissues and slides
Six-week old mice (LAT transgenic or age and gender matched
C57BL/6 mice) were perfused with 10% formalin in PBS by cardiac
puncture. Organs of interest were harvested and ﬁxed in 10% formalin
overnight. Tissues were parafﬁn embedded, sectioned to 5 μm in
thickness, and mounted on positively charged; silanated glass slides
with precautions to avoid RNase contamination. Each slide contained
sections of the same organ from a wild-type mouse, and from
transgenic lines 5221 and 5238. All organs were from female mice
with exception of male reproductive organs.
Slides used for combined staining of ﬂuorescent in situ hybridiza-
tion (FISH) and immunoﬂuorescence (IF) were prepared differently.
Brieﬂy, 6-week old LAT transgenic mice were euthanized by carbon
dioxide inhalation and thoracotomy. Cardiac perfusion with 0.1 M
phosphate-buffered saline (PBS, pH 7.4) was performed immediately,
followed by perfusion with 1% paraformaldehyde (PFA) in 0.1 M
phosphate-buffer (PB, pH 7.4). Dissected dorsal root ganglia (DRGs)
were immersion ﬁxed in 1% PFA in 0.1 M PB for 30 min at 4 °C,
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tissue was then embedded in Tissue-Tek® O.C.T. compound (Sakura
Finetechnical, Tokyo, Japan) and frozen in liquid nitrogen. Serial
sections (7 μm) were collected as four alternate sets onto Superfrost®/
Plus microscope slides (Fisher Scientiﬁc, Pittsburgh, PA) and stored at
−80 °C. These studies were approved by the UCSF Committee on
Animal Research.
Preparation of probes for in situ hybridization
Plasmid pLATin was constructed by inserting the entire HSV-2 LAT
intron sequence into pcDNA3 (Invitrogen) between the Hind III and
Xba I sites. This plasmidwas used as template for in vitro transcription.
Sense (identical to LAT intron) and anti-sense (reverse complement to
LAT intron) cRNA were produced by T7 and SP6 polymerases (Roche),
respectively, following the manufacturer's instruction. The in vitro
transcription products were subjected to partial alkaline hydrolysis to
reduce the size of the RNA transcripts to approximately 200
nucleotides in length as previously described (Wang et al., 2005a).
The RNAs were then biotinylated using a PhotoProbe Biotin labeling
kit (Vector Labs) as described previously (Wang et al., 2005a).
The probe used for FISH was in vitro transcribed from plasmid pYz-
2LAT, which contains a 451 bp fragment (nucleotides 120,394–
120,844) of HSV-2 genomic DNA. To synthesize a DIG-labeled RNA
probe, linearized plasmid was incubated with DIG RNA Labeling Mix
(Roche) and T3 polymerase for 3 h at 37 °C. After treatment with
DNase I, the probe was puriﬁed by passing through a G-50 Sephadex
column (Roche) and dissolved into 50% formamide in nuclease-free
water. The probe concentration was estimated using a DIG-labeled
control RNA on a nylon membrane as described by the manufacturer
(Roche).
In situ hybridization and evaluation of results
ISH was performed as previously described (Wang et al., 2005a)
with slight modiﬁcations. Slides were de-waxed in two xylene baths
for 5 min each, and rehydrated 1 min each in 100%, 95%, 70%, and 50%
ethanol successively. Slides were then dipped in 0.2 N HCl for 20 min
at room temperature (RT), digested with 25 μg/ml proteinase K in
10 mM Tris–Cl pH 7.4, 2 mM CaCl2 at 37 °C for 15 min, incubated in
0.25% (v/v) acetic anhydride with 1.33% (v/v) triethanolamine at pH
8.0 for 10 min at RT, and rinsed with water between each step. Pre-
hybridization was performed in solution containing 50% (v/v)
formamide, 2×SSC, 50 mM Tris–Cl pH 7.4, 1 mM EDTA, 0.02% Ficoll,
0.02% polyvinylpyrrolidone, 500 μg/ml tRNA, 500 μg/ml BSA at 42 °C
for 2 h. The biotinylated probe was denatured at 65 °C for 15 min
and added to the hybridization solution (20% (v/v) dextran sulfate,
50% (v/v) formamide, 300 mM NaCl, 50 mM Tris–Cl pH 7.4, 1 mM
EDTA, 0.02% each of Ficoll and polyvinylpyrrolidone, 10 mM DTT,
500 μg/ml of tRNA and 500 μg/ml of BSA) to 100 ng/ml. After adding
30 μl of hybridization solution to cover the sections, coverslips were
applied and its edges were sealed with rubber cement. Slides were
then incubated at 55 °C overnight. The next day, coverslips were
removed, and slideswerewashed twice in 2×SSC at RT for 5min, twice
in solution with 2xSSC, 1 mM EDTA, and 0.1% (v/v) Triton X-100 at
55 °C for 10 min each, and once in solution with 0.1×SSC, 1 mM EDTA,
0.1% (v/v) Triton X-100 at 55 °C for 20 min. Slides were than treated
with 4 μg/ml RNase A plus 1 U/ml RNase T1 in RNase buffer (10 mM
Tris–Cl pH 7.4, 300mMNaCl) at 37 °C for 20 min andwashed twice for
20min eachwith 2×SSC at 55 °C. To detect the hybridized probe, slides
were incubated in blocking solution containing 1xcasein in TBST
(100 mM Tris–Cl pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween 20) for
40 min. Horseradish peroxidase-streptavidin (Vector Laboratories)
was added to the blocking solution to yield a ﬁnal concentration of
4mg/ml, and slides were incubated for another 30min. After 3washes
in TBST, the slides were developed using a TMB Substrate Kit forHorseradish Peroxidase (Vector Laboratories) for 5 min, and then
rinsed in water brieﬂy. Slides were successively dehydrated in 70%,
95%, 100% ethanol, and again in 100% ethanol for 1 min each,
counterstained with Eosin Y-phloxine, rinsed in 100% ethanol, rinsed
twice in xylene, air dried, andmounted with Permount and coverslips.
Each slide contained sections of the same organ from a wild-type
mouse, and from transgenic lines 5221 and 5238. A TG section was
included in each ISH experiment as a positive and signal intensity
control. Signals in tissues from line 5238 were slightly stronger than
those from the corresponding tissues of line 5221; therefore, line 5238
was used for all of the results reported here. Cells with blue staining
were scored as LAT-positive, and semi-quantiﬁed as strong (dark
blue), moderate (blue), or weak (light blue). Photomicrographs were
taken at 200×, or 400× magniﬁcation. Combined FISH and IF staining
was carried out as previously described (Margolis et al., 2007).
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